SMMT · Categories · Upgrades
SMMT - Analyst upgrades
Summit Therapeutics Inc. (SMMT) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for SMMT
- Summit Therapeutics upgraded by Jefferies with a new price targetJefferies upgraded Summit Therapeutics from Hold to Buy and set a new price target of $25.00
- Summit Therapeutics upgraded by Bernstein with a new price targetBernstein upgraded Summit Therapeutics from Underperform to Mkt Perform and set a new price target of $11.90
- Summit Therapeutics upgraded by Leerink Partners with a new price targetLeerink Partners upgraded Summit Therapeutics from Underperform to Market Perform and set a new price target of $13.00
- Summit Therapeutics upgraded by Barclays with a new price targetBarclays upgraded Summit Therapeutics from Underweight to Equal Weight and set a new price target of $18.00
- Summit Therapeutics upgraded by Citigroup with a new price targetCitigroup upgraded Summit Therapeutics from Neutral to Buy and set a new price target of $35.00 from $23.00 previously